Roberta Gualtierotti: Modern Approaches to Diagnosis and Treatment of Hemophilia A and B
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JTH:
“From factor and non-factor replacement to gene therapy, hemophilia management is evolving rapidly, while hemophilic arthropathy remains a major unmet need.
Proud to share our educational review on the diagnosis and management of Hemophilia A and B, covering genetics, musculoskeletal complications, innovative therapies, cardiovascular comorbidities, and multidisciplinary care.
Educational Review in Press by the International Society on Thrombosis and Haemostasis (ISTH) SSC Subcommittee on FVIII and FIX.”
Title: Diagnosis and management of hemophilia A and B
Authors: Ming Y Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro
Other posts featuring Roberta Gualtierotti on Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin